Lion Bird

Investor type

VC

Founded

2012

AUM

-

Location

Tel Aviv, Tel Aviv District, Israel

Investment Ticket

$0-1 m

Investment Stage

Pre-seed Seed Series A

Region of investment

North America Asia
Investor profile last updated: 21 August, 2026

Profile

Lion Bird is a venture capital firm based in Tel Aviv that focuses on healthcare technology. The firm was co-founded by Jonathan Friedman, Gal Noyman Veksler, Assaf Wahrhaft, Ed Michael, Chaim Friedman, and Itschak Friedman. With a strong team composed of individuals with diverse backgrounds in healthcare, technology, and venture capital, the firm brings a unique set of skills to its portfolio companies. Lion Bird distinguishes itself by supporting early-stage startups that aim to reset healthcare’s relationship with technology.

Lion Bird specializes in healthcare services and healthtech, providing pre-scale capital to startups. The firm typically invests in pre-seed, seed, and early-stage companies, offering check sizes ranging from $0-1 million. Lion Bird primarily focuses on North America and Israel, although it is open to global opportunities. The firm is driven by a mission to create long-term relationships with its portfolio companies, offering guidance and insights to navigate the healthtech landscape.

Notable investments by Lion Bird include companies such as NeuroLabs AI - an opioids dependence prevention platform, TriCares - a next-gen patient management system, and iMDsoft - a provider of Clinical Information Systems. These investments showcase Lion Bird's commitment to supporting innovative solutions in the healthcare sector.

Industry

HealthTech AI Software Healthcare Services E-commerce/Marketplace Consumer Services (B2C)

Contacts

Name
Title
Email
avatar
Jonathan Friedman Partner
Partner
j•••@•••
avatar
Gal Noyman Veksler Partner
Partner
g•••@•••
Upgrade to see contacts
avatar
vIY3mKcu0AXlQkx4 vIY3mKcu0AXlQkx4
vIY3mKcu0AXlQkx4
avatar
vIY3mKcu0AXlQkx4 vIY3mKcu0AXlQkx4
vIY3mKcu0AXlQkx4
avatar
vIY3mKcu0AXlQkx4 vIY3mKcu0AXlQkx4
vIY3mKcu0AXlQkx4
Investment-team contacts for Lion Bird — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Lion Bird

Lion Bird is a venture capital firm. It backs companies at Pre-seed, Seed and Series A, writing tickets of $0-1 m.
Lion Bird is located in Tel Aviv, Tel Aviv District, Israel.
Lion Bird was founded in 2012.
Lion Bird invests in companies and startups in HealthTech, AI, Software, Healthcare Services, E-commerce/Marketplace, Consumer Services (B2C).
Lion Bird invests in companies and startups in North America, Asia.
Lion Bird invests in companies and startups at Pre-seed, Seed, Series A.
Lion Bird usually invests $0-1 m on average.
Lion Bird can be reached through its website lionbird.com, its LinkedIn page and its X account. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Lion Bird — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Lion Bird directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 21 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.